vs
FrontView REIT, Inc.（FVR）与NATURAL ALTERNATIVES INTERNATIONAL INC（NAII）财务数据对比。点击上方公司名可切换其他公司
NATURAL ALTERNATIVES INTERNATIONAL INC的季度营收约是FrontView REIT, Inc.的1.9倍（$34.8M vs $18.2M），FrontView REIT, Inc.净利率更高（2.2% vs -7.3%，领先9.5%），FrontView REIT, Inc.同比增速更快（12.0% vs 2.1%）
天然替代品国际公司（NAI）是一家总部位于美国加利福尼亚州卡尔斯巴德的企业，主打营养补充剂生产，知名产品包括Juice Plus。公司由马克·A·勒杜创立于1980年，生产基地分布在美国加利福尼亚州维斯塔、瑞士与日本，在营养补充剂代工生产领域拥有多年经验。
FVR vs NAII — 直观对比
营收规模更大
NAII
是对方的1.9倍
$18.2M
营收增速更快
FVR
高出9.9%
2.1%
净利率更高
FVR
高出9.5%
-7.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $18.2M | $34.8M |
| 净利润 | $400.0K | $-2.6M |
| 毛利率 | — | 7.2% |
| 营业利润率 | 24.9% | -5.3% |
| 净利率 | 2.2% | -7.3% |
| 营收同比 | 12.0% | 2.1% |
| 净利润同比 | — | -16.5% |
| 每股收益（稀释后） | — | $-0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRNAII
| Q1 26 | $18.2M | — | ||
| Q4 25 | $16.5M | $34.8M | ||
| Q3 25 | $16.8M | $37.7M | ||
| Q2 25 | $17.6M | $33.9M | ||
| Q1 25 | $16.2M | $28.8M | ||
| Q4 24 | — | $34.1M | ||
| Q3 24 | $14.5M | $33.1M | ||
| Q2 24 | — | $29.5M |
净利润FVRNAII
| Q1 26 | $400.0K | — | ||
| Q4 25 | $-4.1M | $-2.6M | ||
| Q3 25 | $4.0M | $-291.0K | ||
| Q2 25 | $-2.9M | $-7.2M | ||
| Q1 25 | $-833.0K | $-2.2M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $-2.4M | $-2.0M | ||
| Q2 24 | — | $-1.9M |
毛利率FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | — | 7.2% | ||
| Q3 25 | — | 11.7% | ||
| Q2 25 | — | 10.4% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 4.8% |
营业利润率FVRNAII
| Q1 26 | 24.9% | — | ||
| Q4 25 | — | -5.3% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | -5.7% | ||
| Q1 25 | — | -7.3% | ||
| Q4 24 | — | -8.2% | ||
| Q3 24 | — | -5.5% | ||
| Q2 24 | — | -8.6% |
净利率FVRNAII
| Q1 26 | 2.2% | — | ||
| Q4 25 | -24.9% | -7.3% | ||
| Q3 25 | 23.9% | -0.8% | ||
| Q2 25 | -16.5% | -21.3% | ||
| Q1 25 | -5.1% | -7.6% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | -16.7% | -6.0% | ||
| Q2 24 | — | -6.4% |
每股收益（稀释后）FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | $-0.19 | $-0.42 | ||
| Q3 25 | $0.19 | $-0.05 | ||
| Q2 25 | $-0.16 | $-1.21 | ||
| Q1 25 | $-0.06 | $-0.37 | ||
| Q4 24 | — | $-0.37 | ||
| Q3 24 | — | $-0.33 | ||
| Q2 24 | — | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.3M | $3.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $514.2M | $67.0M |
| 总资产 | $869.8M | $153.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVRNAII
| Q1 26 | $9.3M | — | ||
| Q4 25 | $13.5M | $3.8M | ||
| Q3 25 | $19.6M | $7.7M | ||
| Q2 25 | $8.4M | $12.3M | ||
| Q1 25 | $3.3M | $10.6M | ||
| Q4 24 | — | $8.7M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | — | $12.0M |
总债务FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FVRNAII
| Q1 26 | $514.2M | — | ||
| Q4 25 | $391.2M | $67.0M | ||
| Q3 25 | $385.2M | $69.0M | ||
| Q2 25 | $369.9M | $68.4M | ||
| Q1 25 | $324.7M | $76.6M | ||
| Q4 24 | — | $79.1M | ||
| Q3 24 | $1.0K | $80.2M | ||
| Q2 24 | — | $82.6M |
总资产FVRNAII
| Q1 26 | $869.8M | — | ||
| Q4 25 | $854.4M | $153.3M | ||
| Q3 25 | $846.8M | $156.9M | ||
| Q2 25 | $856.5M | $151.9M | ||
| Q1 25 | $860.8M | $154.9M | ||
| Q4 24 | — | $156.1M | ||
| Q3 24 | $1.0K | $161.3M | ||
| Q2 24 | — | $162.3M |
负债/权益比FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-6.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.3M |
| 自由现金流率自由现金流/营收 | — | -20.9% |
| 资本支出强度资本支出/营收 | — | 2.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-5.2M |
8季度趋势，按日历期对齐
经营现金流FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | $-6.3M | ||
| Q3 25 | $8.3M | $-4.0M | ||
| Q2 25 | $9.3M | $3.3M | ||
| Q1 25 | $8.1M | $6.0M | ||
| Q4 24 | — | $37.0K | ||
| Q3 24 | — | $-3.4M | ||
| Q2 24 | — | $-2.7M |
自由现金流FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | — | $-7.3M | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $1.9M | ||
| Q1 25 | — | $5.2M | ||
| Q4 24 | — | $-1.0M | ||
| Q3 24 | — | $-3.7M | ||
| Q2 24 | — | $-3.8M |
自由现金流率FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | — | -20.9% | ||
| Q3 25 | — | -13.4% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 18.0% | ||
| Q4 24 | — | -3.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | -12.7% |
资本支出强度FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 3.5% |
现金转化率FVRNAII
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FVR
暂无分部数据
NAII
| Private Label Contract Manufacturing | $32.8M | 94% |
| Patent And Trademark Licensing | $2.0M | 6% |
